186 related articles for article (PubMed ID: 16142898)
1. Structure and biochemical properties of PRL-1, a phosphatase implicated in cell growth, differentiation, and tumor invasion.
Sun JP; Wang WQ; Yang H; Liu S; Liang F; Fedorov AA; Almo SC; Zhang ZY
Biochemistry; 2005 Sep; 44(36):12009-21. PubMed ID: 16142898
[TBL] [Abstract][Full Text] [Related]
2. Trimeric structure of PRL-1 phosphatase reveals an active enzyme conformation and regulation mechanisms.
Jeong DG; Kim SJ; Kim JH; Son JH; Park MR; Lim SM; Yoon TS; Ryu SE
J Mol Biol; 2005 Jan; 345(2):401-13. PubMed ID: 15571731
[TBL] [Abstract][Full Text] [Related]
3. The metastasis-promoting phosphatase PRL-3 shows activity toward phosphoinositides.
McParland V; Varsano G; Li X; Thornton J; Baby J; Aravind A; Meyer C; Pavic K; Rios P; Köhn M
Biochemistry; 2011 Sep; 50(35):7579-90. PubMed ID: 21806020
[TBL] [Abstract][Full Text] [Related]
4. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility.
Fiordalisi JJ; Keller PJ; Cox AD
Cancer Res; 2006 Mar; 66(6):3153-61. PubMed ID: 16540666
[TBL] [Abstract][Full Text] [Related]
5. Reversible oxidation of the membrane distal domain of receptor PTPalpha is mediated by a cyclic sulfenamide.
Yang J; Groen A; Lemeer S; Jans A; Slijper M; Roe SM; den Hertog J; Barford D
Biochemistry; 2007 Jan; 46(3):709-19. PubMed ID: 17223692
[TBL] [Abstract][Full Text] [Related]
6. A selective phosphatase of regenerating liver phosphatase inhibitor suppresses tumor cell anchorage-independent growth by a novel mechanism involving p130Cas cleavage.
Daouti S; Li WH; Qian H; Huang KS; Holmgren J; Levin W; Reik L; McGady DL; Gillespie P; Perrotta A; Bian H; Reidhaar-Olson JF; Bliss SA; Olivier AR; Sergi JA; Fry D; Danho W; Ritland S; Fotouhi N; Heimbrook D; Niu H
Cancer Res; 2008 Feb; 68(4):1162-9. PubMed ID: 18281492
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of human protein tyrosine phosphatase 14 (PTPN14) at 1.65-A resolution.
Barr AJ; Debreczeni JE; Eswaran J; Knapp S
Proteins; 2006 Jun; 63(4):1132-6. PubMed ID: 16534812
[No Abstract] [Full Text] [Related]
8. Structure of human PRL-3, the phosphatase associated with cancer metastasis.
Kim KA; Song JS; Jee J; Sheen MR; Lee C; Lee TG; Ro S; Cho JM; Lee W; Yamazaki T; Jeon YH; Cheong C
FEBS Lett; 2004 May; 565(1-3):181-7. PubMed ID: 15135076
[TBL] [Abstract][Full Text] [Related]
9. Mass spectrometry study of PRL-3 phosphatase inactivation by disulfide bond formation and cysteine into glycine conversion.
Orsatti L; Innocenti F; Lo Surdo P; Talamo F; Barbato G
Rapid Commun Mass Spectrom; 2009 Sep; 23(17):2733-40. PubMed ID: 19639556
[TBL] [Abstract][Full Text] [Related]
10. Role of N and C-terminal tails in DNA binding and assembly in Dps: structural studies of Mycobacterium smegmatis Dps deletion mutants.
Roy S; Saraswathi R; Gupta S; Sekar K; Chatterji D; Vijayan M
J Mol Biol; 2007 Jul; 370(4):752-67. PubMed ID: 17543333
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms of the PRL phosphatases.
Rios P; Li X; Köhn M
FEBS J; 2013 Jan; 280(2):505-24. PubMed ID: 22413991
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of laforin, a dual-specificity protein phosphatase implicated in Lafora disease.
Girard JM; Lê KH; Lederer F
Biochimie; 2006 Dec; 88(12):1961-71. PubMed ID: 17010495
[TBL] [Abstract][Full Text] [Related]
13. Structural insights into molecular function of the metastasis-associated phosphatase PRL-3.
Kozlov G; Cheng J; Ziomek E; Banville D; Gehring K; Ekiel I
J Biol Chem; 2004 Mar; 279(12):11882-9. PubMed ID: 14704153
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a PRL protein tyrosine phosphatase from Plasmodium falciparum.
Pendyala PR; Ayong L; Eatrides J; Schreiber M; Pham C; Chakrabarti R; Fidock DA; Allen CM; Chakrabarti D
Mol Biochem Parasitol; 2008 Mar; 158(1):1-10. PubMed ID: 18096253
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of human TMDP, a testis-specific dual specificity protein phosphatase: implications for substrate specificity.
Kim SJ; Jeong DG; Yoon TS; Son JH; Cho SK; Ryu SE; Kim JH
Proteins; 2007 Jan; 66(1):239-45. PubMed ID: 17044055
[TBL] [Abstract][Full Text] [Related]
16. Mouse PRL-2 and PRL-3, two potentially prenylated protein tyrosine phosphatases homologous to PRL-1.
Zeng Q; Hong W; Tan YH
Biochem Biophys Res Commun; 1998 Mar; 244(2):421-7. PubMed ID: 9514946
[TBL] [Abstract][Full Text] [Related]
17. Structure of the hematopoietic tyrosine phosphatase (HePTP) catalytic domain: structure of a KIM phosphatase with phosphate bound at the active site.
Mustelin T; Tautz L; Page R
J Mol Biol; 2005 Nov; 354(1):150-63. PubMed ID: 16226275
[TBL] [Abstract][Full Text] [Related]
18. PRL-3 and PRL-1 promote cell migration, invasion, and metastasis.
Zeng Q; Dong JM; Guo K; Li J; Tan HX; Koh V; Pallen CJ; Manser E; Hong W
Cancer Res; 2003 Jun; 63(11):2716-22. PubMed ID: 12782572
[TBL] [Abstract][Full Text] [Related]
19. Structure of human DSP18, a member of the dual-specificity protein tyrosine phosphatase family.
Jeong DG; Cho YH; Yoon TS; Kim JH; Son JH; Ryu SE; Kim SJ
Acta Crystallogr D Biol Crystallogr; 2006 Jun; 62(Pt 6):582-8. PubMed ID: 16699184
[TBL] [Abstract][Full Text] [Related]
20. Structural and functional effects of disease-causing amino acid substitutions affecting residues Ala72 and Glu76 of the protein tyrosine phosphatase SHP-2.
Bocchinfuso G; Stella L; Martinelli S; Flex E; Carta C; Pantaleoni F; Pispisa B; Venanzi M; Tartaglia M; Palleschi A
Proteins; 2007 Mar; 66(4):963-74. PubMed ID: 17177198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
